Myron Kulczycky

Potent Antithrombin Activity and Delayed Clearance From the Circulation Characterize Recombinant Hirudin Genetically Fused to Albumin

Summer Syed, Philip D. Schuyler, Myron Kulczycky et al. · Blood · 1997 · 110 citations · Full text

Medicine, Molecular Biology, Pharmacology +11

In vivo recovery and survival of apheresis and whole blood‐derived platelets: a paired comparison in healthy volunteers

Donald M. Arnold, Nancy M. Heddle, Myron Kulczycky et al. · Transfusion · 2006 · 43 citations

Medicine, Hematology, Cell Therapy +16

Inhibition of Thrombin by Antithrombin III and Heparin Cofactor II In Vivo

Longbin Liu, Lori Dewar, Yingqi Song et al. · Thrombosis and Haemostasis · 1995 · 40 citations

Medicine, Biochemistry, Pharmacology +16

Probable regulation of factor VIIa–tissue factor and prothrombinase by factor Xa–TFPI and TFPI <i>in vivo</i>

Isabelle Gouin‐Thibault, Lori Dewar, Sharon Craven et al. · British Journal of Haematology · 1996 · 22 citations

Medicine, Hematology, Hematology Physiology +10

Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.

Okwusidi Ji, N Anvari, Myron Kulczycky et al. · PubMed · 1991 · 18 citations

Medicine, Biochemistry, Enzymology +9